Skip to main content

Table 6 Stepwise multiple regression analysis of the change in HbA1c levels in relation to explanatory variables

From: Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study

Explanatory variable

Regression coefficient

SE

t- value

p-value

Baseline HbA1c (%)

-0.489

0.015

-31.79

< 0.001

Baseline BMI (kg/m2)

0.016

0.006

2.70

0.007

Diabetes drug administration

0.176

0.049

3.59

< 0.001

Change rate in TG (%)

0.004

0.001

6.34

< 0.001

Change rate in TC (%)

0.005

0.001

4.13

< 0.001

Change rate in HDL-C (%)

-0.002

0.001

-1.72

0.085

  1. R2 = 0.3884. Each estimated value indicates the influence in HbA1c per 1 unit change in each variable. The estimated values of diabetes-drug administration indicate the rates of influence in patients with and without drug